EQL PHARMA AB revenue breakdown overview

EQL PHARMA AB revenue for the last year amounted to 263.55 M SEK, the most of which — 264.17 M SEK — came from its highest performing source at the moment, Medicines. The greatest contribution to the revenue figure was made by Sweden — last year it brought EQL PHARMA AB 145.28 M SEK, and the year before that — 162.77 M SEK.